Parallel Bio Launches Clinical Trial in a Dish to Speed Drug Discovery

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company using the immune system to cure disease, today announced the release of its Clinical Trial in a Dish for studying the efficacy and safety of new immunotherapies using human models at the earliest stages of drug discovery. Five pharmaceutical companies, including a Fortune 500 firm, have begun testing 20 drug candidates with the alternative to animal tests. Clinical Trial in a Dish creates human models using immune organoids scal